Correlation Between Walker Dunlop and Pfizer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Walker Dunlop and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Walker Dunlop and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Walker Dunlop and Pfizer Inc CDR, you can compare the effects of market volatilities on Walker Dunlop and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Walker Dunlop with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Walker Dunlop and Pfizer.

Diversification Opportunities for Walker Dunlop and Pfizer

-0.17
  Correlation Coefficient

Good diversification

The 3 months correlation between Walker and Pfizer is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Walker Dunlop and Pfizer Inc CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc CDR and Walker Dunlop is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Walker Dunlop are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc CDR has no effect on the direction of Walker Dunlop i.e., Walker Dunlop and Pfizer go up and down completely randomly.

Pair Corralation between Walker Dunlop and Pfizer

Allowing for the 90-day total investment horizon Walker Dunlop is expected to generate 1.83 times more return on investment than Pfizer. However, Walker Dunlop is 1.83 times more volatile than Pfizer Inc CDR. It trades about 0.05 of its potential returns per unit of risk. Pfizer Inc CDR is currently generating about 0.01 per unit of risk. If you would invest  9,462  in Walker Dunlop on November 5, 2024 and sell it today you would earn a total of  145.00  from holding Walker Dunlop or generate 1.53% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy90.48%
ValuesDaily Returns

Walker Dunlop  vs.  Pfizer Inc CDR

 Performance 
       Timeline  
Walker Dunlop 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Walker Dunlop has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Pfizer Inc CDR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Pfizer is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Walker Dunlop and Pfizer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Walker Dunlop and Pfizer

The main advantage of trading using opposite Walker Dunlop and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Walker Dunlop position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.
The idea behind Walker Dunlop and Pfizer Inc CDR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
CEOs Directory
Screen CEOs from public companies around the world
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities